FDA panel pushing for new limits on access to Vicodin
“Citing concern over increasing reports of addiction and overdoses, a FDA safety panel has recommended new restrictions on access to the commonly-used painkiller Vicodin and other products. The panel voted 19-10 to suggest that Vicodin and other products containing hydrocodone be reclassified as Schedule II, placing it alongside narcotic painkillers like cocaine and percocet. The proposed change would mean that hydrocodone — currently a Schedule III substance — would be subject to stricter regulation regarding access, storage and prescribed dosage.” Continue reading →